Wednesday, October 30, 2024

2:50 PM - 3:35 PM

Room 109

---

Details

Precision medicine has the power to save lives and save costs from the health system. A number of pilots and block-funded projects have generated impressive data in disease areas including oncology, autoimmune disease and paediatric genetic disease. The programmes have demonstrated faster diagnoses, linking patients to specific treatments and reducing unnecessary interventions and costs. In most cases, however, the funding for these programmes is limited and patient access can be challenging. In order to ensure equity of access and to seize the opportunity that precision medicine presents, these programmes now need to become permanently embedded within the national health system as standard-of-care. Here we showcase some of these successful programmes and consider how they can evolve from the translational research setting to become standard-of-care, thus improving the health of the Australian population and ensuring limited budgets are spent effectively.

---

Speaker